miR-223-3p has been characterized as a oncogene in multiple tumors, such as pancreatic cancer, prostate cancer, ovarian cancer, lung cancer and gastric cancer, by targeting different genes, such as FBXW7, SEPT6, SOX11, EPB41L335–38. Here, SOX11 is linked to ovarian carcinoma.